Second Line Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
3,969
-248
-6% -$57.8K 0.19% 55
2026
Q1
$969K Sell
4,217
-36
-0.8% -$8.38K 0.18% 66
2025
Q4
$880K Buy
4,253
+90
+2% +$17.8K 0.18% 56
2025
Q3
$772K Sell
4,163
-1,485
-26% -$254K 0.16% 64
2025
Q2
$863K Sell
5,648
-105
-2% -$16.1K 0.2% 57
2025
Q1
$954K Buy
5,753
+417
+8% +$65.2K 0.25% 55
2024
Q4
$772K Sell
5,336
-617
-10% -$95.6K 0.21% 52
2024
Q3
$965K Buy
5,953
+1,681
+39% +$268K 0.26% 52
2024
Q2
$624K Buy
4,272
+1,134
+36% +$169K 0.19% 56
2024
Q1
$496K Buy
3,138
+264
+9% +$42K 0.16% 60
2023
Q4
$450K Buy
+2,874
New +$441K 0.18% 59

Other funds holding JNJ

Second Line Capital's JNJ Position: Q2 2026 in Review

Second Line Capital reduced its Johnson & Johnson (JNJ) stake by 5.9% in Q2 2026, selling an estimated $57.8K and leaving 3,969 shares worth $1.01M. The position accounts for 0.19% of the portfolio, ranked #55.

Second Line Capital first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,676 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Second Line Capital held 3,969 shares of Johnson & Johnson worth $1.01M as of Q2 2026.
  • Second Line Capital sold 248 Johnson & Johnson shares in Q2 2026, an estimated $57.8K.
  • Johnson & Johnson made up 0.19% of Second Line Capital's portfolio in Q2 2026, its #55 holding.
  • Second Line Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Second Line Capital's 13F filing for Q2 2026, filed 12 Aug 2026.